Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation
- DOI
- 10.1016/j.omta.2026.201742
- Published
- 2026-06
- Container
- Molecular Therapy Advances
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omta.2026.201742,
title = {Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation},
author = {Hayato Nakatani and Masashi Tachibana and Rika Onishi and Takato Nakagaki and Ken J. Ishii and Kahori Shimizu and Fuminori Sakurai and Hiroyuki Mizuguchi},
year = {2026},
journal = {Molecular Therapy Advances},
doi = {10.1016/j.omta.2026.201742},
url = {https://doi.org/10.1016/j.omta.2026.201742}
}RIS
TY - JOUR TI - Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation AU - Hayato Nakatani AU - Masashi Tachibana AU - Rika Onishi AU - Takato Nakagaki AU - Ken J. Ishii AU - Kahori Shimizu AU - Fuminori Sakurai AU - Hiroyuki Mizuguchi PY - 2026 JO - Molecular Therapy Advances DO - 10.1016/j.omta.2026.201742 UR - https://doi.org/10.1016/j.omta.2026.201742 ER -
APA
Nakatani, H., Tachibana, M., Onishi, R., Nakagaki, T., Ishii, K. J., Shimizu, K., Sakurai, F., & Mizuguchi, H. (2026). Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation. Molecular Therapy Advances. https://doi.org/10.1016/j.omta.2026.201742
Source records
- crossref · retrieved 2026-09-27T02:01:48.262Z